Aug 3, 2026 08:30AM
Aug 3, 2026 08:30AM
Jul 13, 2026 08:31AM
Jul 13, 2026 08:30AM
Jun 2, 2026 04:05PM
Jun 2, 2026 04:05PM
May 14, 2026 04:09PM Cue Biopharma appoints new CEO, raises $30 million in first quarter
May 14, 2026 04:07PM
Apr 30, 2026 04:15PM
Apr 30, 2026 04:15PM
Apr 30, 2026 04:07PM
Apr 30, 2026 04:05PM
Apr 22, 2026 08:37AM
Apr 22, 2026 08:37AM Cue Biopharma Announces 1-for-30 Reverse Stock Split
Apr 15, 2026 08:01AM
Apr 15, 2026 08:00AM
Apr 8, 2026 08:00AM
Apr 8, 2026 08:00AM
Mar 27, 2026 04:05PM
Mar 27, 2026 04:05PM
Mar 26, 2026 08:00AM Cue Biopharma to Host Virtual R&D Day Event on April 7, 2026
Mar 16, 2026 04:05PM
Mar 9, 2026 08:00AM
Feb 17, 2026 08:00AM
Feb 12, 2026 08:02AM
Feb 12, 2026 08:00AM
Nov 12, 2025 04:05PM
Nov 6, 2025 08:02AM Cue Biopharma partners with ImmunoScape on solid tumor cell therapy
Nov 6, 2025 08:00AM
Sep 29, 2025 09:00AM
Sep 29, 2025 09:00AM
Aug 13, 2025 08:00AM
Aug 12, 2025 04:05PM
Jul 16, 2025 08:00AM
Jul 16, 2025 08:00AM Cue Biopharma Reports New Complete Response and Confirmed 50% Overall Response Rate in Ongoing Phase 1 Trial of CUE-101 and Pembrolizumab in Recurrent/Metastatic HPV+ Head and Neck Cancer
Jul 1, 2025 04:05PM
Jul 1, 2025 04:05PM
Jun 24, 2025 04:48PM
Jun 24, 2025 04:48PM
May 12, 2025 04:05PM
May 8, 2025 08:00AM
Apr 14, 2025 05:00PM Boehringer Ingelheim and Cue Biopharma (CUE) partner to develop next-generation treatment for autoimmune and inflammatory diseases
Apr 14, 2025 05:00PM
Mar 31, 2025 04:20PM
Nov 14, 2024 04:05PM
Nov 14, 2024 08:00AM
Nov 8, 2024 01:31PM
Nov 8, 2024 01:30PM
Sep 9, 2024 08:03AM Cue Biopharma Inc. (CUE) Appoints Lucinda Warren as Chief Business Officer
Sep 9, 2024 08:00AM

327,801 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All